Takeru Funakoshi

Scopus著者プロファイル

ウェブサイトhttps://k-ris.keio.ac.jp/html/100005696_ja.html

年別の研究成果

Pureに変更を加えた場合、すぐここに表示されます。

フィンガープリント

Takeru Funakoshiが活動している研究トピックを掘り下げます。このトピックラベルは、この研究者の研究成果に基づきます。これらがまとまってユニークなフィンガープリントを構成します。

1 類似のプロファイル

820 被引用数
14 h-index
57 Article
21 Letter
3 Comment/debate
2 Review article
その他
- 1 Editorial
- 1 Short survey

Adoptive cell therapy using tumor-infiltrating lymphocytes for melanoma refractory to immune-checkpoint inhibitors
Hirai, I., Funakoshi, T., Kamijuku, H., Fukuda, K., Mori, M., Sakurai, M., Koda, Y., Kato, J., Mori, T., Watanabe, N., Noji, S., Yaguchi, T., Iwata, T., Ota, S., Fujita, T., Tanosaki, R., Handa, M., Okamoto, S., Amagai, M. & Kawakami, Y., 2021 8, In: Cancer science. 112, 8, p. 3163-3172 10 p.
研究成果: Article › 査読

Open Access
AIM2 regulates anti-tumor immunity and is a viable therapeutic target for melanoma
Fukuda, K., Okamura, K., Riding, R. L., Fan, X., Afshari, K., Haddadi, N. S., McCauley, S. M., Guney, M. H., Luban, J., Funakoshi, T., Yaguchi, T., Kawakami, Y., Khvorova, A., Fitzgerald, K. A. & Harris, J. E., 2021 7 29, In: Journal of Experimental Medicine. 218, 9, e20200962.
研究成果: Article › 査読
Autoimmune and inflammatory diseases occur in cases of drug-induced hypersensitivity syndrome but not in suspected cases
Shiiya, C., Ouchi, T., Funakoshi, T., Amagai, M. & Takahashi, H., 2021 1, In: Journal of Dermatology. 48, 1, p. e45-e46
研究成果: Letter › 査読

1 被引用数 (Scopus)
Estimating copy number using next-generation sequencing to determine ERBB2 amplification status
Nakamura, K., Aimono, E., Oba, J., Hayashi, H., Tanishima, S., Hayashida, T., Chiyoda, T., Kosaka, T., Hishida, T., Kawakubo, H., Kitago, M., Okabayashi, K., Funakoshi, T., Okita, H., Ikeda, S., Takaishi, H. & Nishihara, H., 2021 4, In: Medical Oncology. 38, 4, 36.
研究成果: Article › 査読

Open Access
Impact of the changes in the completion lymph node dissection criteria and approval of adjuvant therapies on the real-world outcomes of Japanese stage III melanoma patients
Ogata, D., Tanese, K., Nakamura, Y., Otsuka, M., Namikawa, K., Funakoshi, T., Yoshikawa, S., Tsutsui, K., Nakama, K., Jinnai, S., Kiyohara, Y., Takahashi, A. & Yamazaki, N., 2021, (Accepted/In press) In: International Journal of Clinical Oncology.
研究成果: Article › 査読

舩越建

フィンガープリント

ネットワーク

詳細を開く

Adoptive cell therapy using tumor-infiltrating lymphocytes for melanoma refractory to immune-checkpoint inhibitors

AIM2 regulates anti-tumor immunity and is a viable therapeutic target for melanoma

Autoimmune and inflammatory diseases occur in cases of drug-induced hypersensitivity syndrome but not in suspected cases

Estimating copy number using next-generation sequencing to determine ERBB2 amplification status

Impact of the changes in the completion lymph node dissection criteria and approval of adjuvant therapies on the real-world outcomes of Japanese stage III melanoma patients

舩越 建

フィンガープリント

ネットワーク

研究成果

Adoptive cell therapy using tumor-infiltrating lymphocytes for melanoma refractory to immune-checkpoint inhibitors

AIM2 regulates anti-tumor immunity and is a viable therapeutic target for melanoma

Autoimmune and inflammatory diseases occur in cases of drug-induced hypersensitivity syndrome but not in suspected cases

Estimating copy number using next-generation sequencing to determine ERBB2 amplification status

Impact of the changes in the completion lymph node dissection criteria and approval of adjuvant therapies on the real-world outcomes of Japanese stage III melanoma patients

舩越建